AAAAAA

   
Results: 1-10 |
Results: 10
Overexpression, purification, and crystal structure of native ER alpha LBD
Authors: Eiler, S Gangloff, M Duclaud, S Moras, D Ruff, M
Citation: S. Eiler et al., Overexpression, purification, and crystal structure of native ER alpha LBD, PROT EX PUR, 22(2), 2001, pp. 165-173
Different ligands-different receptor conformations: Modeling of the hER alpha LBD in complex with agonists and antagonists
Authors: Egner, U Heinrich, N Ruff, M Gangloff, M Mueller-Fahrnow, A Wurtz, JM
Citation: U. Egner et al., Different ligands-different receptor conformations: Modeling of the hER alpha LBD in complex with agonists and antagonists, MED RES REV, 21(6), 2001, pp. 523-539
Crystal structure of the Stromelysin-3 (MMP-11) catalytic domain complexedwith a phosphinic inhibitor mimicking the transition-state
Authors: Gall, AL Ruff, M Kannan, R Cuniasse, P Yiotakis, A Dive, V Rio, MC Basset, P Moras, D
Citation: Al. Gall et al., Crystal structure of the Stromelysin-3 (MMP-11) catalytic domain complexedwith a phosphinic inhibitor mimicking the transition-state, J MOL BIOL, 307(2), 2001, pp. 577-586
Crystal structure of a mutant hER alpha ligand-binding domain reveals key structural features for the mechanism of partial agonism
Authors: Gangloff, M Ruff, M Eiler, S Duclaud, S Wurtz, JM Moras, D
Citation: M. Gangloff et al., Crystal structure of a mutant hER alpha ligand-binding domain reveals key structural features for the mechanism of partial agonism, J BIOL CHEM, 276(18), 2001, pp. 15059-15065
Estrogen receptor transcription and transactivation Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors
Authors: Ruff, M Gangloff, M Wurtz, JM Moras, D
Citation: M. Ruff et al., Estrogen receptor transcription and transactivation Structure-function relationship in DNA- and ligand-binding domains of estrogen receptors, BREAST CA R, 2(5), 2000, pp. 353-359
Crystal structure of the human RXR alpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid
Authors: Egea, PF Mitschler, A Rochel, N Ruff, M Chambon, P Moras, D
Citation: Pf. Egea et al., Crystal structure of the human RXR alpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid, EMBO J, 19(11), 2000, pp. 2592-2601
Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors
Authors: Kannan, R Ruff, M Kochins, JG Manly, SP Stoll, I El Fahime, M Noel, A Foidart, JM Rio, MC Dive, V Basset, P
Citation: R. Kannan et al., Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors, PROT EX PUR, 16(1), 1999, pp. 76-83
Progress in the development of an 8-kV light-triggered thyristor with integrated protection functions
Authors: Ruff, M Schulze, HJ Kellner, U
Citation: M. Ruff et al., Progress in the development of an 8-kV light-triggered thyristor with integrated protection functions, IEEE DEVICE, 46(8), 1999, pp. 1768-1774
VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death
Authors: Brenneman, DE Hauser, J Spong, CY Phillips, TM Pert, CB Ruff, M
Citation: De. Brenneman et al., VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death, BRAIN RES, 838(1-2), 1999, pp. 27-36
Features that distinguish those who die from asthma from community controls with asthma
Authors: Tough, SC Hessel, PA Ruff, M Green, FHY Mitchell, I Butt, JC
Citation: Sc. Tough et al., Features that distinguish those who die from asthma from community controls with asthma, J ASTHMA, 35(8), 1998, pp. 657-665
Risultati: 1-10 |